YD Bio (NASDAQ:YDES) Shares Up 3.1% – Here’s What Happened

YD Bio Limited (NASDAQ:YDES) shot up 3.1% during mid-day trading on Wednesday . The stock traded as high as $3.32 and last traded at $3.0320. 22,050 shares were traded during mid-day trading, an increase of 76% from the average session volume of 12,558 shares. The stock had previously closed at $2.94.

Analyst Ratings Changes

Separately, Wall Street Zen raised YD Bio from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

YD Bio Price Performance

The firm has a 50 day moving average price of $4.88.

Institutional Trading of YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC increased its holdings in YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.